PEREGRINE PHARMACEUTICALS IN's ticker is PPHMXXXX and the CUSIP is 713661304. A total of 85 filers reported holding PEREGRINE PHARMACEUTICALS IN in Q2 2014. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $206,000 | +38.3% | 338,378 | +48.0% | 0.00% | – |
Q1 2017 | $149,000 | +1141.7% | 228,628 | +495.7% | 0.00% | – |
Q4 2016 | $12,000 | -73.9% | 38,378 | -63.9% | 0.00% | – |
Q3 2016 | $46,000 | +17.9% | 106,378 | 0.0% | 0.00% | – |
Q2 2016 | $39,000 | -44.3% | 106,378 | -35.5% | 0.00% | – |
Q1 2016 | $70,000 | -61.5% | 165,010 | +5.5% | 0.00% | – |
Q4 2015 | $182,000 | +13.8% | 156,415 | +0.0% | 0.00% | – |
Q3 2015 | $160,000 | -21.6% | 156,362 | +0.4% | 0.00% | – |
Q2 2015 | $204,000 | -13.6% | 155,667 | -11.1% | 0.00% | – |
Q1 2015 | $236,000 | +112.6% | 175,104 | +118.0% | 0.00% | – |
Q4 2014 | $111,000 | +640.0% | 80,332 | +626.0% | 0.00% | – |
Q3 2014 | $15,000 | -53.1% | 11,065 | -36.4% | 0.00% | – |
Q2 2014 | $32,000 | +357.1% | 17,405 | +369.1% | 0.00% | – |
Q1 2014 | $7,000 | +40.0% | 3,710 | -5.1% | 0.00% | – |
Q4 2013 | $5,000 | +25.0% | 3,910 | +16.9% | 0.00% | – |
Q3 2013 | $4,000 | 0.0% | 3,345 | -5.6% | 0.00% | – |
Q2 2013 | $4,000 | – | 3,545 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BAXTER BROS INC | 170,506 | $232,000 | 0.09% |
First Heartland Consultants, Inc. | 86,204 | $117,000 | 0.05% |
Rotella Capital Management, Inc. | 20,769 | $28,000 | 0.03% |
FIDGEON TIMOTHY F | 33,000 | $45,000 | 0.02% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 547,800 | $746,000 | 0.02% |
Freedom Investment Management, Inc. | 74,127 | $101,000 | 0.02% |
Investors Capital Advisory Services | 63,288 | $86,000 | 0.02% |
REYNOLDS CAPITAL MANAGEMENT LLC | 10,000 | $14,000 | 0.01% |
Tower Research Capital LLC (TRC) | 76,914 | $104,000 | 0.01% |
PINNACLE FINANCIAL PARTNERS INC | 20,000 | $27,000 | 0.01% |